France – Matériels médicaux, pharmaceutiques et produits de soins personnnels – MSP008 - FOURNITURE DE MEDICAMENTS POUVANT FAIRE L?OBJET D?UNE MISE EN CONCURRENCE ET PRESTATIONS ASSOCIEES
AI summary
This tender concerns the supply of competitive medicines and associated services for GIP RESAH. The procurement covers pharmaceutical products that may be subject to competitive bidding, along with related service provisions to support the supply chain.
Pharmaceutical suppliers, authorized medicine distributors, and pharmaceutical service providers operating in France are eligible to bid.
Suppliers must be pharmaceutical distributors or manufacturers authorized to supply medicines in France. They must comply with all regulatory requirements for pharmaceutical distribution and demonstrate capacity to meet service obligations.
Frequently asked questions
What is this tender about?
This tender concerns the supply of competitive medicines and associated services for GIP RESAH. The procurement covers pharmaceutical products that may be subject to competitive bidding, along with related service provisions to support the supply chain.
What are the requirements for suppliers?
Suppliers must be pharmaceutical distributors or manufacturers authorized to supply medicines in France. They must comply with all regulatory requirements for pharmaceutical distribution and demonstrate capacity to meet service obligations.
What type of company should bid?
Pharmaceutical suppliers, authorized medicine distributors, and pharmaceutical service providers operating in France are eligible to bid.
Who is the buyer?
The buyer is GIP RESAH.
MSP008 - FOURNITURE DE MEDICAMENTS POUVANT FAIRE L?OBJET D?UNE MISE EN CONCURRENCE ET PRESTATIONS ASSOCIEES
Documents not listed
A10BK - INHIBITEUR DU NA-GLUCOSE CO-TRANSPORTEUR 2 (SGLT2)
B01AB - HEPARINE DE BAS POIDS MOLECULAIRE (indication en préventif)
B01AB05 - ENOXAPARINE (indication en préventif)
C02KX01 - BOSENTAN 32 MG
D01BA02 - TERBINAFINE FORME ORALE
J01DH02 - MEROPENEM 500 MG INJECTABLE
J06BA02 - IG HUMAINES POLYVALENTES IV 10% PRETES A L'EMPLOI - STABILISE A LA GLYCINE + POLYSORBATE
J07AL02 - VACCINS ANTIPNEUMOCOCCIQUES - ADULTE
J07AL02 - VACCINS ANTIPNEUMOCOCCIQUES - ENFANT
L01CB01 - ETOPOSIDE - DOSAGES FAIBLES
L01CB01 - ETOPOSIDE - DOSAGE FORT
L01DB07- MITOXANTRONE
L01EK01 - AXITINIB
L01EX03 - PAZOPANIB
L04AK02 - TERIFLUNOMIDE
M05BX04 - DENOSUMAB - DOSAGE FAIBLE
M05BX04 - DENOSUMAB - DOSAGE FORT
N01AX14 - ESKETAMINE
N05AD01- HALOPERIDOL
N05AH01 - LOXAPINE DOSE ORALE - DOSAGE FAIBLE
N05AH01 - LOXAPINE DOSE ORALE - DOSAGE FORT
N05BA04 - OXAZEPAM 5MG
R03DX05 - OMALIZUMAB
S01LA05 - AFLIBERCEPT
V03AF04 - LEVOFOLINATE DE CALCIUM 10 MG/ML
V03AF04 - LEVOFOLINATE DE CALCIUM 25 MG/ML
ZZZ - A16AB06- SACROSIDASE
Scoring criteria not specified
Computing match…
AI document analysis
We read the tender PDFs and DOCX files and surface key requirements, deadlines, budget and red flags.
Loading…